This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Hemant Harishchandra Kamble: Innovator in Pharmaceutical Chemistry
Introduction: Hemant Harishchandra Kamble is a distinguished inventor based in Mumbai, India. With a keen focus on pharmaceutical innovations, he has made significant contributions to the field, particularly through his groundbreaking patent in drug preparation.
Latest Patents: Kamble holds one notable patent: a process for the preparation and purification of rivaroxaban. This innovation plays a crucial role in the creation of this important anticoagulant, which is widely used in the medical industry to prevent blood clots.
Career Highlights: Currently, Hemant Kamble is employed at Glenmark Pharmaceuticals Limited, a prominent player in the pharmaceutical sector. His role has allowed him to leverage his expertise in biochemical processes to advance drug development.
Collaborations: Throughout his career, Kamble has collaborated with notable professionals in his field, including Shrikant Prabhakar Keshav and Sanjay Shashikant Bhise. Together, they have fostered an environment of innovation that has led to significant advancements in pharmaceutical research.
Conclusion: Hemant Harishchandra Kamble is a valuable asset to the field of pharmaceutical sciences. His inventive work on rivaroxaban and collaborative spirit exemplify the drive for innovation that is essential in today’s competitive landscape. As he continues to contribute to Glenmark Pharmaceuticals Limited, his future endeavors are anticipated to further propel advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile